Peroxisome Proliferator-Activated Receptor α Agonists Increase Nitric Oxide Synthase Expression in Vascular Endothelial Cells

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y. I., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,716

The L-Arginine-Nitric Oxide Pathway

Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

Fulton, D. J., Gratton, J., McCabe, T. J. D., Fontana, J. T., Fujio, Y., Walsh, K. X., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,616

Roles of PPARs in health and disease

Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956

Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism

Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., & Fruchart, J.-C. (1998) · Circulation · doi:10.1161/01.cir.98.19.2088 · Cited by 1,786

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

Caterina, R. D., Libby, P., Peng, H., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,781

Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo

Joannidès, R., Haefeli, W. E., Linder, L., Richard, V. J., Bakkali, E. H., Thuillez, C., & Lüscher, T. F. (1995) · Circulation · doi:10.1161/01.cir.91.5.1314 · Cited by 1,622

Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

Simoncini, T., Hafezi‐Moghadam, A., Brazil, D. P., Ley, K. F., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436

Fatty Acids, Eicosanoids, and Hypolipidemic Agents Identified as Ligands of Peroxisome Proliferator-Activated Receptors by Coactivator-Dependent Receptor Ligand Assay

Krey, G. D., Braissant, O., L’Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., & Wahli, W. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.6.0007 · Cited by 1,230

PPAR-αAgonist Fenofibrate Upregulates Tetrahydrobiopterin Level through Increasing the Expression of Guanosine 5′-Triphosphate Cyclohydrolase-I in Human Umbilical Vein Endothelial Cells

Liu, J., Lu, C., Li, F., Wang, H., He, L., Hao, Y., Chen, A. F., An, H., Wang, X., Hong, T., et al. (2011) · PPAR Research · doi:10.1155/2011/523520 · Cited by 21

Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy

Harmer, J. A., KEECH, A. C., Veillard, A., Skilton, M. R., Marwick, T. H., Watts, G. F., Meredith, I. T., & Celermajer, D. S. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.038 · Cited by 21

Coronary Flow Velocity Reserve is Improved by PPAR‐α Agonist Fenofibrate in Patients with Hypertriglyceridemia

Wang, G., He, L., Liu, J., Yu, J., Feng, X., Li, F., Hao, Y., Mao, J., Hong, T., Chen, A. F., et al. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00307.x · Cited by 18

Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials.

Sahebkar, A., Giua, R., Pedone, C., Ray, K., Vallejo-Vaz, A., & Costanzo, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.011 · Cited by 18

Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target?

Morel, J., & Singer, M. (2014) · Intensive Care Medicine Experimental · doi:10.1186/2197-425x-2-9 · Cited by 18

PPARα ligand clofibrate ameliorates blood pressure and vascular reactivity in spontaneously hypertensive rats

Yousefipour, Z., & Newaz, M. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.193 · Cited by 17

Peroxisome proliferator-activated receptor α activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat

Banks, T., & Oyekan, A. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f2f0f3 · Cited by 17

Activation of PPARα by Fenofibrate Attenuates the Effect of Local Heart High Dose Irradiation on the Mouse Cardiac Proteome

Azimzadeh, O., Subramanian, V., Sievert, W., Merl‐Pham, J., Oleksenko, K., Rosemann, M., Multhoff, G., Atkinson, M. J., & Tapio, S. (2021) · Biomedicines · doi:10.3390/biomedicines9121845 · Cited by 16

PPAR α is involved in the multitargeted effects of a pretreatment with atorvastatin in experimental stroke

Ouk, T., Potey, C., Laprais, M., Gautier, S., Hanf, R., Darteil, R., Staels, B., Duriez, P., & Bordet, R. (2013) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12035 · Cited by 16

Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney

Speeckaert, M. M., Vanfraechem, C., Speeckaert, R., & Delanghe, J. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.01.006 · Cited by 16

Fenofibrate, an Anti-Dyslipidemia Drug, Elicits the Dilation of Isolated Porcine Retinal Arterioles: Role of Nitric Oxide and AMP-Activated Protein Kinase

Omae, T., Nagaoka, T., Tanano, I., Kamiya, T., & Yoshida, A. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8841 · Cited by 16

Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects

Cortes-Lopez, F., Sánchez-Mendoza, A., Centurión, D., Cervantes-Pérez, L. G., Castrejón-Téllez, V., del Valle‐Mondragón, L., Soria‐Castro, E., Ramírez, V., Sánchez‐López, A., Pastelín-Hernández, G. S., et al. (2021) · PPAR Research · doi:10.1155/2021/8895376 · Cited by 16

Parishin alleviates vascular ageing in mice by upregulation of Klotho

Zhao, X., Zhou, S., Liu, Y., Gong, C., Xiang, L., Li, S., Wang, P., Wang, Y., Sun, L., Zhang, Q., et al. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17740 · Cited by 13

Modulatory Effect of Fenofibrate on Endothelial Production of Neutrophil Chemokines IL-8 and ENA-78

Price, E. T., Welder, G. J., & Zineh, I. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6368-7 · Cited by 15

Peroxisome proliferator-activated receptors and the vascular system: beyond their metabolic effects.

Marchesi, C., & Schiffrin, E. (2008) · Journal of the American Society of Hypertension : JASH · doi:10.1016/j.jash.2007.12.007 · Cited by 17

Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.

(2005) · PubMed Central · Cited by 15

Effect of fenofibrate on serum nitric oxide levels in patients with hypertriglyceridemia

Esenboğa, K., Çiçek, Ö. F., Oktay, A. A., Ayral, P. A., & Gürlek, A. (2019) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/94161 · Cited by 14

Fenofibrate improves vascular endothelial function in diabetic mice

Xin, R., An, D., Li, Y., Fu, J., Huang, F., & Zhu, Q. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108722 · Cited by 15

Pravastatin and Gemfibrozil Modulate Differently Hepatic and Colonic Mitochondrial Respiration in Tissue Homogenates from Healthy Rats

Herminghaus, A., Laser, E., Schulz, J., Truse, R., Vollmer, C., Bauer, I., & Picker, O. (2019) · Cells · doi:10.3390/cells8090983 · Cited by 14

Regulation of Endothelial Nitric Oxide Synthase by PPAR Agonists: Molecular and Clinical Perspectives

Watts, G. F., & Staels, B. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000125706.86492.69 · Cited by 14

Effects of low and high doses of fenofibrate on protein, amino acid, and energy metabolism in rat

Holeček, M., & Vodeničarovová, M. (2020) · International Journal of Experimental Pathology · doi:10.1111/iep.12368 · Cited by 13

Effects of green cardamom supplementation on serum levels of Hs-CRP, dimethylarginine, nitric oxide and blood pressure in patients with type 2 diabetes: A randomized, double-blind, placebo controlled, clinical trial

Zahedi, S. G., Koohdani, F., Qorbani, M., Nasli‐Esfahani, E., Aghasi, M., Khoshamal, H., Keshavarz, A. A., & Sotoudeh, G. (2022) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2022.100555 · Cited by 14

Mice lacking the peroxisome proliferator-activated receptor α gene present reduced number of dopamine neurons in the substantia nigra without altering motor behavior or dopamine neuron decline over life.

González-Aparicio, R., Flores, J. A., Tasset, I., Túnez, I., & Fernández-Espejo, E. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.062 · Cited by 13

Fenofibrate increases neuronal vasoconstrictor response in mesenteric arteries from diabetic rats: Role of noradrenaline, neuronal nitric oxide and calcitonin gene-related peptide

del Campo, L., Blanco‐Rivero, J., & Balfagón, G. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.056 · Cited by 12

Activation of Peroxisome Proliferator-Activated Receptor α in Megakaryocytes Reduces Platelet-Derived Growth Factor-BB in Platelets

Hashizume, S., Akaike, M., Azuma, H., Ishikawa, K., Yoshida, S., Sumitomo-Ueda, Y., Yagi, S., Ikeda, Y., Iwase, T., Aihara, K., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.5868 · Cited by 12

PPARα: its role in the human metabolic syndrome

Azhar, S., & Kelley, G. (2007) · Future Lipidology · doi:10.2217/17460875.2.1.31 · Cited by 12

Endothelial nitric oxide synthase impairment is restored by clofibrate treatment in an animal model of hypertension

Cervantes-Pérez, L. G., Ibarra-Lara, L., Escalante, B., del Valle‐Mondragón, L., Vargas‐Robles, H., Pérez‐Severiano, F., Pastelı́n, G., & Sánchez-Mendoza, A. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.04.006 · Cited by 12

Fenofibrate Reverses Dysfunction of EPCs Caused by Chronic Heart Failure

Huang, W., Yin, W., Chen, J.-S., Huang, P., Chen, J., & Lin, S. (2019) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-019-09889-y · Cited by 12

PPARα agonist Wy14643 suppresses cathepsin B in human endothelial cells via transcriptional, post-transcriptional and post-translational mechanisms

Reichenbach, G., Starzinski‐Powitz, A., Sloane, B. F., Doll, M., Kippenberger, S., Bernd, A., Kaufmann, R., & Meißner, M. (2012) · Angiogenesis · doi:10.1007/s10456-012-9314-9 · Cited by 12

How PPAR-alpha mediated inflammation may affect the pathophysiology of chronic kidney disease

Masenga, S. K., Desta, S., Hatcher, M. D., Kirabo, A., & Lee, D. L. (2024) · Current Research in Physiology · doi:10.1016/j.crphys.2024.100133 · Cited by 16

The peroxisome proliferator‐activated receptor alpha agonist fenofibrate decreases airway reactivity to methacholine and increases endothelial nitric oxide synthase phosphorylation in mouse lung

Becker, J., Delayre‐Orthez, C., Frossard, N., & Pons, F. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.00935.x · Cited by 11

Topical hADSCs-HA Gel Promotes Skin Regeneration and Angiogenesis in Pressure Ulcers by Paracrine Activating PPARβ/δ Pathway

Jin, C., Zhao, R., Hu, W., Wu, X., Zhou, L., Shan, L., & Wu, H. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s474628 · Cited by 9

Peroxisome proliferator-activated receptor ɑ (PPARɑ)–cytochrome P450 epoxygenases-soluble epoxide hydrolase axis in ER + PR + HER2− breast cancer

Tauber, Z., Kolečková, M., & Čížková, K. (2019) · Medical Molecular Morphology · doi:10.1007/s00795-019-00240-7 · Cited by 9

Comparative cardiometabolic effects of fibrates and omega-3 fatty acids

Han, S. H., Oh, P. C., Lim, S. K., Eckel, R. H., & Koh, K. K. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.223 · Cited by 9

Fenofibrate and Pioglitazone Do Not Ameliorate the Altered Vascular Reactivity in Aorta of Isoproterenol-treated Rats

Fukuda, L. E., Davel, A. P., Veríssimo-Filho, S., Lopes, L. R., Cachofeiro, V., Lahera, V., & Rossoni, L. V. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31818a8927 · Cited by 9

Declining nitric oxide bioavailability in cardiovascular aging: mechanistic insights and emerging interventions

Adhikari, H., Patel, P., Javvaji, N., Crabtree, M. J., & Simon, J. N. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2025.14 · Cited by 11

Regulation of cerebrovascular endothelial peroxisome proliferator activator receptor alpha expression and nitric oxide production by clofibrate

Yakubu, M. A., Nsaif, R. H., & Oyekan, A. (2010) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657365 · Cited by 8

Factors Modulating Fibrates Response: Therapeutic Implications and Alternative Strategies

Panadero, M. I., González, M. D. C., Herrera, E., & Bocos, C. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009789044356 · Cited by 9

Restoration of Endothelial Function inPparα−/−Mice by Tempol

Silswal, N., Parelkar, N. K., Andresen, J. J., & Wacker, M. (2015) · PPAR Research · doi:10.1155/2015/728494 · Cited by 8

Wy14643 improves vascular function in the aorta of the spontaneously hypertensive rat mainly by activating peroxisome proliferator-activated receptors alpha

Qu, C., Leung, S. W. S., Vanhoutte, P. M., & Man, R. Y. K. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.015 · Cited by 9

Nitric Oxide in Vascular Damage and Regeneration

Claudio Napoli, A., Lerman, L. O., Balestrieri, M. L., & Ignarro, L. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373866-0.00020-4 · Cited by 7

Effect of clofibrate on vascular reactivity in a model of high blood pressure secondary to aortic coarctation

Cervantes-Pérez, L. G., Ibarra-Lara, L., Rubio, M. E., Escalante, B., Pérez‐Severiano, F., Soria‐Castro, E., Ramírez-Ortega, M. D. C., & Sánchez-Mendoza, M. A. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70347-9 · Cited by 6

Anti-atherogenic properties of fibrates may be largely due to their anti-inflammatory effects

Ye, H., & Zhao, S. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.09.036 · Cited by 6

Efeitos da rosiglitazona sobre a função endotelial em indivíduos não-diabéticos com síndrome metabólica

Bahia, L., Kraemer‐Aguiar, L. G., Villela, N. R., Bottino, D. A., Godoy‐Matos, A. F., & Bouskela, E. (2006) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2006000500007 · Cited by 5

Cardiovascular Actions of the Peroxisome Proliferator‐Activated Receptor‐Alpha (PPARα) Agonist Wy14,643

Zahradka, P. C. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00008.x · Cited by 5

Different actions of peroxisome proliferator-activated receptors: molecular mechanisms and clinical importance

Simonson, G., & Kendall, D. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000216965.36504.be · Cited by 5

Modulación del PPARα por agentes farmacológicos y naturales y sus implicaciones metabólicas

Panadero, M. I., González, M. D. C., Herrera, E., & Bocos, C. (2008) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(08)75789-9 · Cited by 4

Interactions of PPAR α and GLUT4 in DOCA/salt-induced renal injury in mice.

Ighodaro, I., Eric, O., & Oyekan, A. (2013) · PubMed · Cited by 3

Microencapsulated Leukotrienes Augment Antimicrobial Activity against Infections

Nicolete, R., & Nicolete, L. D. D. F. (2012) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.s5-001 · Cited by 3

Sex-Specific Cardiovascular Protection in Developing Metabolic Syndrome: The Role of AMPK

Kvandová, M., Zemančíková, A., Berenyiová, A., Waczulı́ková, I., Magyarova, S., Mičurová, A., Török, J., Grman, M., Tomášová, L., Mišák, A., et al. (2025) · Antioxidants · doi:10.3390/antiox14070843 · Cited by 3

Tissue Distribution and Versatile Functions of PPARs

Youssef, J., & Badr, M. Z. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-420-3_5 · Cited by 2

Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension

Imig, J. D. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1186477 · Cited by 2

Role of PPARs in the Pathogenesis of the Metabolic Syndrome

Medina‐Gómez, G., Gray, S. L., & Vidal‐Puig, A. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50015-2 · Cited by 2

Cardiovascular Disease and Insulin Resistance

Ajjan, R., & Grant, P. J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_138 · Cited by 2

Review: Vascular protective effects of peroxisome proliferator-activated receptor agonists

Cariou, B., Fruchart, J., & Staels, B. (2005) · The British Journal of Diabetes · doi:10.1177/14746514050050030301 · Cited by 2

Comparative effectiveness of pemafibrate versus bezafibrate on hepatic and vascular endothelial function in patients with coronary artery disease and metabolic dysfunction-associated steatotic liver disease

Nakamura, A., Kagaya, Y., Saito, H., Kanazawa, M., Miura, M., Kondo, M., & Endo, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1750308 · Cited by 1

Biochemical Alterations and Endothelial Dysfunction in Hypercholesterolemic Rats: Effects of Bezafibrate

Abo-Zaid, O. A., Hasanin, M., & Hanafi, A. (2013) · Journal of Investigational Biochemistry · doi:10.5455/jib.20130305012038 · Cited by 1

Evaluation of PPAR-α Agonist effect on Kidney Performance Through Increment of Nitric Oxide During Hyperglycemia-Induced Nephropathy in Rat

Yaribeygi, H., & Mohammadi, M. T. (2016) · Razavi International Journal of Medicine · doi:10.17795/rijm37670 · Cited by 1

Comparisons of pharmacokinetics and NO‐releasing of nitrofibriate and fenofibrate after oral administration in rats

Yang, Y., Cheng, Q., Liu, X., Liu, Z., Li, T., Jiang, X., & Wang, L. (2016) · Biomedical Chromatography · doi:10.1002/bmc.3777 · Cited by 1

277

Yilmaz, B. A., & Törüner, F. B. (2013) · CRC Press eBooks · doi:10.1201/b14907-9 · Cited by 1

Gemfibrozil Improves Microcirculatory Oxygenation of Colon and Liver without Affecting Mitochondrial Function in a Model of Abdominal Sepsis in Rats

Kuebart, A., Gross, K., Maicher, C., Sonnenschein, M., Raupach, A., Schulz, J., Truse, R., Hof, S., Marcus, C., Vollmer, C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010262 · Cited by 1

Lipid metabolism: Is liver X receptor (LXR) a regulator of adipocyte differentiation? Consequences of stearoyl-CoA desaturase activation by LXR

Narce, M., & Poisson, J. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200412000-00012 · Cited by 1

Papel del receptor alpha actitivado por proliferadores de peroxisoma en la fisiopatología del sistema cardiovascular

Illnait-Ferrer, J. (2014) · Revista CENIC. Ciencias biológicas

Peroxisome Proliferator‐Activated Receptor δ: A Target with a Broad Therapeutic Potential for Drug Discovery

Gregoire, F. M. (2008) · PPAR Research · doi:10.1155/2008/736362

Fenofibrate Prevents Myocardial Ischemia-Reperfusion Injury in Rat Hearts

Gurfateh, S., Rohilla, A., & Razia, K. (2011)

Computational Drug Target Pathway Discovery: A Bayesian Network Approach

Imoto, S., Tamada, Y., Araki, H., & Miyano, S. (2011) · Springer eBooks · doi:10.1007/978-3-642-16345-6_24

Microencapsulated Leukotrienes Augment Antimicrobial Activity against

Montello, R. J. (2011)

Cardiovascular and mental health benefits of soy consumption: role of soy isoflavones.

Thorp, A. A. (2008) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)

PHARMACOLOGICAL EFFECTS OF GEMFIBROZIL ON SOME CARDIOVASCULAR PREPARATIONS OF EXPERIMENTAL ANIMALS

Ouda, E. A. E.-A. (2016) · Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences · doi:10.21608/ajps.2016.6914

Biological and Chemical Investigation of Panamanian Plants for Potential Utility against Metabolic Syndrome

Vásquez, Y. (2016)

Involvement of Peroxisome Proliferator-Activated Receptor-a and g in Apelin Action on the Kidney in Type 2 Diabetic Rat Model

GOMAA, M. D. N. M. M. R. S., & Saeed, J. (2020) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2020.110866

Cardiac transcriptomic remodeling in metabolic syndrome

Jaquet, K., Mügge, A., & Hamdani, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822258-4.00011-0

Effects of Atorvastatin and Gemfibrozil on Mice Corpus Cavernosum In Vitro

Erkoseoglu, I., Kadıoğlu, M., Kesim, S. M., Yariş, E., & Kalyoncu, N. İ. (2025) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.70042

Intérêt des approches pléiotropes dans l'ischémie cérébrale : modulation pharmacologique par l'atorvastatine

Potey, C. (2013) · theses.fr (ABES) · doi:10.70675/a32cd53dze390z4eb8z8998z2d0b3d7b3a83

Fenofibrate increases endothelial nitric oxide synthase expression in bovine aortic endothelial cells

Li, Z. (2004) · Zhongguo bingli shengli zazhi

Effects of bezafibrate on the expression of endothelial nitric oxide synthase gene and its mechanisms in cultured bovine endothelial cells

Wang, Y., Wang, Y., Yang, Q., Yan, J., Zhao, C., Cianflone, K., & Wang, D. W. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.008 · Cited by 40

Bezafibrate up-regulate endothelial nitric oxide gene expressions via peroxisome proliferator-activated receptors alpha-dependent and independent pathways in cultured Bovine endothelial cells

Dao-we, W. (2006) · Zhonghua xinxueguanbing zazhi

The peroxisome proliferator‐activated receptor alpha agonist fenofibrate decreases airway reactivity to methacholine and increases endothelial nitric oxide synthase phosphorylation in mouse lung

Becker, J., Delayre‐Orthez, C., Frossard, N., & Pons, F. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.00935.x · Cited by 11

PPARs ligands antagonizes Ang-induced decrease in endothelial NO production by upregulating eNOS expression

Shi-ming, L. (2006) · Zhongguo bingli shengli zazhi